Specifications TableSubjectVeterinary Science and Veterinary MedicineSpecific subject areaEquine medicine, Equine exercise, Exercise physiology, Blood filtration technique, Plasmapheresis, Haematology BiochemistryType of dataTables, FigureHow data were acquired-[Physiological parameters]{.ul}:\
Physiological parameters were measured in the two groups using the same procedures as in clinical examination.•Heart rate: the pulse on the facial artery was taken.•Respiratory rate: Horse\'s chest movements were counted.•Rectal temperature: recorded using a digital thermometer (range, 32--42 °C; accuracy, 0.1 °C).-[Plasmapheresis]{.ul}: was performed by using a Hemofenix® plasmapheresis machine commercialized by Hemofenix-France utilizing Trackpore® technology (Dubna Moscow region-Russian Federation).\
[-Blood sampling]{.ul}: Blood samples were obtained by jugular venipuncture and were collected in BD-Vacutainer EDTA tubes for haematological parameters and in lithium heparin'BD-Vacutainer tubes for biochemical parameters.\
-[Haematological parameters analysis]{.ul} was performed by using a veterinary cell-counter automate, the Celltac VET MEK-6550® haematology (Nihon Kohden, Tomioka-Japan) and its reagents, Hemolynac·3 MEK-660I, Isotonac·4 MEK-641I, Cleanac MEK-520I (Celltac VET MEK-6550 J/K haematology, Nihon Kohden, Tomioka-Japan).\
-[Biochemical parameters]{.ul} were assayed using the veterinary Skyla-VB1® automate analyzer (Lite-On Technology Corporation, Hsinchu-Taiwan) and reagent disc (Equine Panel- Product code 900-150, skylaTM VB1® reagent disc, Hsinchu-Taiwan).\
-[Lactate concentrations]{.ul} were determined using Lactate-Pro™ 2 analyzer (Busimedic®, S.L, San Sebastián-Spain).Data formatRaw DataParameters for data collectionThe data were obtained from 12 show jumping horses that were divided into plasmapheresis (n = 6) and control (n = 6) groups. Each group contained 3 females and 3 males of Anglo-Hispano-Arab breed, aged from 4 to 12 years and weighing 400 kg. Throughout the study, horses were healthy and their clinical state was rigorously controlled.Description of data collectionAll horses underwent the same daily physical exercise for three consecutive days. Following the 3rd day exercise, a plasmapheresis session was performed only on horses of plasmapheresis group. All physiological and haemato-biochemical parameters data presented in this article were obtained from blood samples taken simultaneously on horses of the plasmapheresis and control groups before and after each exercise and after plasmapheresis session for the following 4 days.Data source locationRoyal Guard of Tétouan\
Tétouan\
Morocco\
Latitude: 35.5730287\
Longitude: 5.3515084\
GPS Coordinates: 35° 34′ 22.904″ N 5° 21′ 5.429″ WData accessibilityRaw Data is available with this articleRelated research articleRéda Daden^a,b^, Fatima Zahraa Zarhouni^a^, Jamal Chakir^c^, Mohammed Piro^d^, Mohamed Rachid Achaaban^a^, Mohammed Ouassat^a^ & Khalid El Allali^a^.\
"Plasmapheresis Effect on Haematological and Biochemical Parameters in Athletic Horses Subjected To Exercise"\
Journal of Equine Veterinary Science\
<https://doi.org/10.1016/j.jevs.2019.07.006>**Value of the Data**•This data represents for the first time the changes in physiological, haematological and biochemical parameters in horses subjected to a plasmapheresis session after three days of exercise. It can be thus taken into consideration by other researchers interested in both sport physiology and blood filtration techniques field.•Such data can be used as a reference series for comparative approaches in the field. By providing relevant information, it allows a reuse and a better interpretation of the results. This is also useful for future studies.•In addition, the present data show informations that are complementing the related article and can be interesting for readers of the Data in Brief journal.

1. Data {#sec1}
=======

Data shown in this article provide information about the effect of plasmapheresis on physiological, haematological and biochemical parameters in athletic horses subjected to exercise. Horses of both plasmapheresis and control groups underwent each morning an exercise of 30 min/day, during 3 successive days (Day −2, −1 and 0). Following the exercise session of the 3rd day (Day 0) a plasmapheresis session was performed only on the horses of the plasmapheresis group. The control group were maintained in the same environment but without being subjected to plasmapheresis. Data of haemato-biochemical parameters were obtained by analyzing blood samples collected before and after exercise and plasmapheresis. [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"} describe clinical parameters variations subsequent to an exercise and a plasmapheresis session. [Table 4](#tbl4){ref-type="table"}, [Table 5](#tbl5){ref-type="table"}, [Table 6](#tbl6){ref-type="table"}, [Table 7](#tbl7){ref-type="table"}, [Table 8](#tbl8){ref-type="table"}, [Table 9](#tbl9){ref-type="table"}, [Table 10](#tbl10){ref-type="table"} represent each one parameters of red hemogram before and after exercise also before and after a plasmapheresis session. [Table 11](#tbl11){ref-type="table"}, [Table 12](#tbl12){ref-type="table"}, [Table 13](#tbl13){ref-type="table"}, [Table 14](#tbl14){ref-type="table"}, [Table 15](#tbl15){ref-type="table"} describe parameters of white hemogram and their changes subsequent to exercise and plasmapheresis session. [Table 16](#tbl16){ref-type="table"}, [Table 17](#tbl17){ref-type="table"}, [Table 18](#tbl18){ref-type="table"}, [Table 19](#tbl19){ref-type="table"}, [Table 20](#tbl20){ref-type="table"}, [Table 21](#tbl21){ref-type="table"}, [Table 22](#tbl22){ref-type="table"}, [Table 23](#tbl23){ref-type="table"}, [Table 24](#tbl24){ref-type="table"}, [Table 25](#tbl25){ref-type="table"}, [Table 26](#tbl26){ref-type="table"}, [Table 27](#tbl27){ref-type="table"}, [Table 28](#tbl28){ref-type="table"}, [Table 29](#tbl29){ref-type="table"}, [Table 30](#tbl30){ref-type="table"}, represent variations of biochemical parameters before and after graded exercise and plasmapheresis session.Table 1Rectal temperature (°C)[a](#tbl1fna){ref-type="table-fn"} in jumping horses subsequent to an exercise and a plasmapheresis session.Table 1GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito37.540.137.540.237.540.338.137.537.837.637.5Dahbi37.24037.840.837.540.937.538.338.638.538.6Chamaa37.840.637.640.637.540.538.137.937.637.537.6Dahman37.639.937.639.937.640.138.237.537.537.537.5Damaa37.539.937.64037.640.138.337.637.537.537.6Dalilano37.84137.639.937.640.138.237.537.537.537.5Plasmapheresis GroupBeluc37.639.937.639.937.640.138.237.537.537.537.5Chaddy37.540.837.540.937.540.937.538.338.638.538.6Printanier37.740.937.840.837.740.937.937.837.837.937.8Daoudiya37.740.637.84137.840.940.137.937.837.837.8Camelia37.640.637.640.637.540.538.137.937.637.537.6Doualiya37.839.937.940.237.540.139.138.237.538.539.5[^1]Table 2Heart rate (beats per minute)[a](#tbl2fna){ref-type="table-fn"} changes in jumping horses subsequent to an exercise and a plasmapheresis session.Table 2GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito3611236116361203836363836Dahbi3612036126361233636363636Chamaa3212036132361233836363836Dahman3611036115361103636383636Damaa3612036132361523636383638Dalilano3611536110361103636383636Plasmapheresis GroupBeluc3611036113361003636383636Chaddy3610436100361203636363636Printanier4516744162441524644454644Daoudiya4111044120441184544424440Camelia3211036120361143836363836Doualiya3811240132421104036383836[^2]Table 3Respiratory rate (breaths per minute)[a](#tbl3fna){ref-type="table-fn"} changes in jumping horses subsequent to an exercise and a plasmapheresis session.Table 3GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito2468266826682824242424Dahbi2068246420722428242824Chamaa2068246220662424202424Dahman2064286824662824222424Damaa2064286824662824222424Dalilano2066286824682824222424Plasmapheresis GroupBeluc2064286824662824222424Chaddy2464207224682428242824Printanier2898326828722428282828Daoudiya2864286326682826242424Camelia2468246320682424202424Doualiya2468286824662824282624[^3]Table 4Red blood cell count (10^6^/μl)[a](#tbl4fna){ref-type="table-fn"} changes in jumping horses subsequent to exercise and a plasmapheresis session.Table 4GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito8.8810.68.5810.410.213.28.017.477.928.628.71Dahbi8.6313.38.5810.48.6110.78.6710.39.68.178.63Chamaa8.7112.29.4211.911.214.3108.499.118.569.01Dahman7.5912.19.7411.69.3411.210.27.587.757.537.56Damaa7.5912.19.7411.68.0211.97.997.587.757.537.56Dalilano7.5312.19.7411.68.112.49.527.757.537.7413.4Plasmapheresis GroupBeluc11.711.39.7412.910.213.113.212.310.610.49.31Chaddy11.215.39.9414.511.214.713.512.110.39.2710.3Printanier8.2611.48.311.58.3511.311.910.310.27.967.43Daoudiya7.5612.19.4211.99.7912.612.810.27.967.8210.2Camelia8.7112.29.4212.310.412.412.78.036.957.2210.5Doualiya7.9211.47.3911.58.3511.3137.2588.198.39[^4]Table 5Changes in blood hemoglobin concentrations (g/dl)[a](#tbl5fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 5GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito14.216.913.717.511.717.41312.313.214.114.3Dahbi13.319.313.216.713.216.813.515.814.612.713.4Chamaa1317.314.117.414.517.812.912.913.413.213Dahman1118.215.517.615.816.212.111.310.91110.8Damaa1115.611.514.311.614.111.312.711.311.912.7Dalilano11.118.215.517.615.818.111.810.9111118.9Plasmapheresis GroupBeluc1717.715.519.415.319.819.614.614.815.613.8Chaddy15.224.413.419.214.319.719.213.913.512.514.5Printanier12.217.312.1171216.8171212.211.811.1Daoudiya10.51814.117.414.517.119.212.81210.713.6Camelia1317.314.117.416.817.517.512.212.310.815.8Doualiya10.817.310.3171216.81712.311.912.612.2[^5]Table 6Blood hematocrit (g/dL)[a](#tbl6fna){ref-type="table-fn"} changes in jumping horses subsequent to exercise and a plasmapheresis session.Table 6GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito43.952.542.551.736.552.939.539.93835.234Dahbi40.459.840.45440.350.841.144.93937.739.5Chamaa39.552.442.552.444.453.338.938.53634.238.8Dahman3454.943.850434936.238.537.434.935.6Damaa36.648.536.85335.956.148.943.14951.334.4Dalilano3354.942.9524354.83637.7363734.2Plasmapheresis GroupBeluc37.553.343.857.945.759.25931.935.433.735.6Chaddy37.95341.3534361.460.932.833.332.632.8Printanier36.151.336.8533751.25332.731.128.230.6Daoudiya38.555.242.552.444.453.95431.240.137.331.3Camelia42.152.442.552.4455350.637.736.838.135.4Doualiya3751.332.851.433.851.25334.736.73333.8[^6]Table 7Changes in blood mean corpuscular volume (fL)[a](#tbl7fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 7GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito44.846454644.645.244.844.644.444.544.6Dahbi41.44441.544.141.34341.741.341.641.240.9Chamaa44.345.244.24544.345.244.944.444.144.344.5Dahman42.145.645.445.545.44342.742.342.242.242.2Damaa4546.844.645.544.745.245.645.34545.345.5Dalilano43.445.24345.344.345.243.94343.645.543.9Plasmapheresis GroupBeluc45.44645.546.14445.545.54444.94545Chaddy46.84746.347.4454647.1454447.247Printanier41.44341.345.545.445.945.245.144.945.244.9Daoudiya44.845.44545.645.245.545.345.1454544.7Camelia41.242.840.942.341.242.142.441.641.341.841.7Doualiya44.845.44545.64343.143.244.9454342.9[^7]Table 8Changes in blood mean corpuscular hemoglobin (pg)[a](#tbl8fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 8GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito14.915.714.915.114.915.114.814.514.814.814.8Dahbi13.515.413.815.513.115.214.513.813.613.513.2Chamaa14.815.214.71514.414.814.414.91515.114.9Dahman14.514.914.715.114.815.314.21413.913.713.4Damaa14.91514.715.114.715.415.315.215.11515.1Dalilano1415.213.81514.415.214.714.614.114.615.1Plasmapheresis GroupBeluc151615.216.21516.316.21514.915.215Chaddy15.616.215.416.115.515.715.815.415.615.515.5Printanier1414.11414.61415.315.414.314.314.914.5Daoudiya14.51514.614.914.414.714.914.614.514.614.8Camelia13.914.113.514.213.913.813.513.913.613.613.8Doualiya14.51514.31514.514.614.814.514.614.214.1[^8]Table 9Changes in blood mean corpuscular hemoglobin concentration (g/dL)[a](#tbl9fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 9GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito32.33332.233.832.132.932.933.433.132.832.5Dahbi32.933.332.733.932.833.132.832.833.233.133Chamaa32.93332.833.132.733.433.132.532.832.832.9Dahman32.433.232.333.132.433.133.432.732.532.632.6Damaa32.93332.833.132.733.433.232.532.13233Dalilano32.433.232.333.132.4333332.9333332.6Plasmapheresis GroupBeluc32.433.232.533.532.533.433.132.432.33232.5Chaddy32.733.233.233.232.633.133.633.63332.732.1Printanier33.333.732.833.532.433.232.232.13232.533.1Daoudiya3332.632.833.132.733.131.632.13232.432.6Camelia32.93332.833.132.233.232.432.632.532.632.5Doualiya32.333.732.133.532.433.633.23232.93333.2[^9]Table 10Blood platelet count (10^3^/μl)[a](#tbl10fna){ref-type="table-fn"} variations in jumping horses subsequent to exercise and a plasmapheresis session.Table 10GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito172179171193155173164143158152148Dahbi152146146165148145149135139144135Chamaa125170136198134164133147158149153Dahman143127143119141119131150152148151Damaa152170149198134180128139147156163Dalilano1431271431191411149515214813377Plasmapheresis GroupBeluc144162143134144122138141159170136Chaddy154154153157156140156150150104150Printanier159173161173145171150144148155157Daoudiya145151136198134157151151142143110Camelia1251701361981271861110911111473Doualiya157173179173145171174157168194135[^10]Table 11White blood cell count (10^3^/μl)[a](#tbl11fna){ref-type="table-fn"} changes in jumping horses subsequent to exercise and a plasmapheresis session.Table 11GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito8.710.48.49.99.19.511.88.57.98.18Dahbi5.68.16.37.78.2107.65.85.75.65.1Chamaa10.814.210.613.910.213.214.511.110.810.711Dahman810.18.412.18.51112.49.38.98.67.2Damaa7.910.68.612.610.210.57.68.47.67.87.9Dalilano8.110.18.412.1108.99.98.98.610.25.9Plasmapheresis GroupBeluc7.87.58.47.798.112.68.77.87.67.6Chaddy11.115.310.613.41116.416.814.511.310.111.3Printanier9.311.79.411.69.911.8129.48.88.27.8Daoudiya8.813.810.613.910.712.312.510.39.88.15.8Camelia10.814.210.613.910.414.314.698.67.86.9Doualiya9.411.79.711.69.911.812.49.39.79.39[^11]Table 12Changes in blood lymphocyte count (10^3^/μl)[a](#tbl12fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 12GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito6.98.26.38.97.99.67.37.276.56.4Dahbi5.210.65.610.36.49.18.36.25.55.65.7Chamaa6.910.96.310.36.87.210.16.27.56.46.2Dahman5.910.65.811.55.99.69.87.57.25.85.9Damaa5.39.35.410.37.49.28.66.56.35.95.5Dalilano5.89.56.36.36.29.49.37.56.25.56.2Plasmapheresis GroupBeluc47.16.67.98.38.68.87.56.25.75.6Chaddy12.59.95.99.76.367.27.97.866.5Printanier5.98.85.897.310.610.88.58.17.86Daoudiya6.99.76.49.67.39.610.28.17.57.26.8Camelia6.413.16.49.17.210.610.97.26.96.86.3Doualiya5.99.25.8107.91212.676.96.85.8[^12]Table 13Variations of blood Monocyte count (10^3^/μl)[a](#tbl13fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 13GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito0.20.30.20.20.20.30.40.20.20.30.4Dahbi0.30.30.20.30.20.30.20.20.10.30.1Chamaa0.30.30.30.40.30.50.30.20.20.10.2Dahman0.20.40.30.50.20.40.20.30.30.10.2Damaa0.30.30.30.40.30.40.30.20.20.20.3Dalilano0.20.40.30.50.20.50.20.30.30.30.1Plasmapheresis GroupBeluc0.20.30.10.30.20.40.40.20.30.30.4Chaddy0.10.30.10.30.20.60.50.40.30.10.4Printanier0.30.20.20.20.30.30.20.60.20.30.1Daoudiya0.20.40.20.30.30.30.40.20.30.30.1Camelia0.30.30.40.30.20.40.60.10.20.20.2Doualiya0.20.20.20.40.20.30.20.20.20.20.2[^13]Table 14Blood Eosinophil count (10^3^/μl)[a](#tbl14fna){ref-type="table-fn"} changes in jumping horses subsequent to exercise and a plasmapheresis session.Table 14GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito0.20.20.10.20.10.60.40.20.20.10.1Dahbi0.30.20.40.40.30.90.50.10.20.30.3Chamaa0.31.30.30.90.30.70.30.30.30.20.1Dahman0.30.60.10.40.30.90.50.30.30.20.3Damaa0.31.30.30.90.30.80.50.40.40.30.2Dalilano0.20.60.20.40.30.90.60.20.20.20.1Plasmapheresis GroupBeluc0.30.40.30.10.30.60.10.30.100Chaddy0.10.90.20.70.21.61.50.50.40.30.2Printanier0.40.80.30.90.30.80.90.40.10.30.5Daoudiya0.41.40.30.90.30.80.90.40.60.50.3Camelia0.31.30.30.90.410.80.30.70.20.3Doualiya0.20.90.40.90.50.80.90.40.40.90.2[^14]Table 15Blood Granulocyte count (10^3^/μl)[a](#tbl15fna){ref-type="table-fn"} variations in jumping horses subsequent to exercise and a plasmapheresis session.Table 15GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito5.96.15.19.65.45.76.15.45.555.3Dahbi3.25.335.81.92.632.62.90.52.6Chamaa6.16.23.58.66.36.46.46.46.25.76.3Dahman3.73.63.58.55.36.85.24.84.93.63.4Damaa7.910.68.67.67.612.68.47.86.510.57.9Dalilano3.73.66.13.35.36.84.93.84.52.12Plasmapheresis GroupBeluc2.85.25.26.36.36.16.56.34.64.35.1Chaddy2.87.42.56.53.477.33.53.43.53.2Printanier4.65.25.76.35.16.56.35.14.84.24.1Daoudiya5.56.35.16.46.36.56.56.65.44.32.8Camelia6.27.56.57.23.47.37.54.74.343.2Doualiya4.66.55.76.85.16.26.455.154.6[^15]Table 16Blood glucose concentration (mmol/L)[a](#tbl16fna){ref-type="table-fn"} in jumping horses submitted to plasmapheresis after graded exercise.Table 16GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito5.264.564.55.65.75.75.65.55.6Dahbi7.264.95.84.86.85.35.75.45.35.2Chamaa5.57.16.25.85.36.96.25.85.35.65.9Dahman4.65.64.55.75.36.35.75.45.34.94.8Damaa5.57.16.28.26.66.25.85.65.35.66.2Dalilano4.65.64.55.75.36.35.14.85.34.95.4Plasmapheresis GroupBeluc4.85.65.36.35.45.25.45.25.14.94.6Chaddy5.65.84.96.64.99.35.55.55.44.94.6Printanier3.86.53.64.54.56.45.74.84.74.64.6Daoudiya5.57.166.36.16.35.56.86.75.95.6Camelia7.85.35.55.65.45.43.64.84.74.84.7Doualiya5.87.15.98.25.65.85.954.74.65.5[^16]Table 17Modifications of blood urea concentrations (mmol/L)[a](#tbl17fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 17GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito4.14.24.14.13.83.93.93.83.93.83.6Dahbi4.85.34.95.45.15.55.55.65.14.94.7Chamaa5.35.95.66.366.25.85.65.34.64.7Dahman55.45.25.85.35.65.35.45.64.94.6Damaa3.94.144.24.5543.93.83.73.5Dalilano55.45.15.855.74.94.94.84.74.6Plasmapheresis GroupBeluc4.34.94.64.744.23.63.23.83.73.2Chaddy3.93.944.33.83.93.23.53.233.1Printanier4.54.64.855.15.84.944.14.14Daoudiya3.84.13.94.24.65.355.15.34.23.1Camelia66.566.56.37.86.35.65.45.65.6Doualiya5.15.25.15.24.94.64.34.244.14[^17]Table 18Changes in blood creatinine concentrations (mg/dL)[a](#tbl18fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 18GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito1.92.21.9222.421.81.922.1Dahbi1.71.91.82.122.32.122.32.12Chamaa1.21.71.21.91.31.81.31.81.71.51.4Dahman1.82.51.92.41.81.921.61.71.81.6Damaa1.41.71.41.91.522.21.81.71.51.6Dalilano1.82.51.92.42.12.22.11.81.71.81.5Plasmapheresis GroupBeluc1.62.31.721.61.91.81.81.71.81.8Chaddy1.51.51.51.81.621.71.61.61.51.4Printanier1.72.31.52.31.82.21.81.71.81.71.8Daoudiya1.31.71.31.91.42.31.91.61.71.61.6Camelia1.41.61.71.91.51.51.41.51.31.41.3Doualiya1.61.71.51.91.51.51.41.41.81.71.5[^18]Table 19Blood Alkaline phosphatase concentrations (U/L)[a](#tbl19fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 19GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito158162141184145174174159158159160Dahbi849888888611210296959393Chamaa117141127144140154150132139140141Dahman110124141142140142130129123110101Damaa117141127144140136143141139140122Dalilano110112112142111125124124123110118Plasmapheresis GroupBeluc100104140156135140164137136132129Chaddy13113988156136177141141132129121Printanier110113111117115119117112111112110Daoudiya117141127144140147123111111110110Camelia161139160142159140148171165169146Doualiya116141127144140126133123111112110[^19]Table 20Blood Gama Glutamyl Transferase concentrations (U/L)[a](#tbl20fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 20GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito1010101010101010101010Dahbi1010101010101010101010Chamaa1114151818221716101213Dahman1010101010101010101010Damaa1114151818111010101210Dalilano1010101010131010101010Plasmapheresis GroupBeluc1010101010101010101010Chaddy1010101010151013121212Printanier1010111210131010101010Daoudiya1114151818131411111010Camelia1012131112101010111110Doualiya1110101818111110101010[^20]Table 21Blood Total bilirubin concentrations (mg/dL)[a](#tbl21fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 21GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito2.22.51.92.52.42.32.32.22.22.42.3Dahbi1.73.81.61.71.61.62.32.121.81.3Chamaa1.21.71.21.51.21.21.31.61.71.51.4Dahman1.61.81.92.62.23.21.81.91.51.61.4Damaa1.21.71.21.51.41.22.62.31.71.51.7Dalilano1.61.81.92.61.63.21.91.21.51.61.2Plasmapheresis GroupBeluc3.11.93.23.73.53.23.12.62.12.31.5Chaddy1.71.91.61.81.622.11.61.71.81.6Printanier0.72.11.922.12.12.21.71.61.50.8Daoudiya1.221.21.51.21.71.81.71.61.31.1Camelia1.62.31.41.61.51.71.61.61.61.51.8Doualiya1.62.451.51.51.21.611.71.71.71.6[^21]Table 22Blood Sodium concentrations (mmol/L)[a](#tbl22fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 22GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito138143138144143143138138142143144Dahbi146139139139138144140138143145144Chamaa138146142153142146140138142146144Dahman138143138142139149139138129121123Damaa138146142153142149138146142146142Dalilano138151138142136140139139136138140Plasmapheresis GroupBeluc136146146146142147148144141139133Chaddy143142139144139146150146143139137Printanier145149144145146145149145145149150Daoudiya138145142146145148148147142139138Camelia142145140146139145147146143140148Doualiya148146141146146144147146145149141[^22]Table 23Blood Potassium concentrations (mmol/L)[a](#tbl23fna){ref-type="table-fn"} in jumping horses submitted to plasmapheresis after graded exercise.Table 23GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito4.44.64.34.74.24.74.64.54.73.53.1Dahbi4.44.74.44.54.14.34.14.34.44.54.8Chamaa3.64.34.14.24.44.84.33.933.23.3Dahman4.24.64.54.64.74.94.53.53.53.83.9Damaa3.64.54.14.24.45.25.14.64.64.53.1Dalilano4.24.64.54.64.75.154.833.23Plasmapheresis GroupBeluc4.44.74.74.64.24.94.14.94.34.24.2Chaddy3.94.34.24.13.94.84.14.34.24.44.5Printanier4.24.85.35.14.85.24.13.13.63.22.7Daoudiya3.84.64.24.64.45.54.23.43.33.32.2Camelia44.63.64.34.23.53.64.73.63.63.8Doualiya4.24.54.24.24.44.44.13.13.33.24.1[^23]Table 24Blood Calcium concentrations (mg/dL)[a](#tbl24fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 24GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito111211.61211.312.211.911.311.811.911.9Dahbi11.9121111.911.31111.611.911.611.711.8Chamaa11.31211.612.111.211.810.911.611.511.912Dahman11.312.611.211.611.412.311.611.111.811.311.3Damaa11.912.311.612.111.312.211.911.811.511.911.2Dalilano11.311.51111.411.411.711.311.611.811.311.4Plasmapheresis GroupBeluc11.71211.61211.611.911.511.511.511.611.7Chaddy11.311.611.31211.512.310.410.610.511.211.3Printanier1112.21112.311.411.911.311.811.810.610.8Daoudiya11.51211.212.111.312.311.411.911.611.511.2Camelia10.511.310.812.311.11210.910.710.810.611.2Doualiya11.31211.212.311.312.310.311.61111.811.2[^24]Table 25Plasma albumin (g/L)[a](#tbl25fna){ref-type="table-fn"} changes in jumping horses subsequent to exercise and a plasmapheresis session.Table 25GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito3437323733363633343533Dahbi3641343736383835333334Chamaa3539363738383838333537Dahman3239323833393736353729Damaa3539363738383537363635Dalilano3339323833383632353630Plasmapheresis GroupBeluc3438353835363034353634Chaddy3638343935423236363833Printanier3134323532362632313232Daoudiya3539363738392835343334Camelia3632373035312634353232Doualiya3139293738332531313232[^25]Table 26Plasma globulin (g/L)[a](#tbl26fna){ref-type="table-fn"} changes in jumping horses subsequent to exercise and a plasmapheresis session.Table 26GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito3336313531363332333435Dahbi3138293031353131323432Chamaa3437333533383934333233Dahman2837313534363835343637Damaa3437333533383933323332Dalilano2837313534383233323233Plasmapheresis GroupBeluc3435343833302830333631Chaddy2542294636472328292629Printanier3033333530352630343334Daoudiya3437333533383230292726Camelia3032323139322739343335Doualiya3437363533413234292728[^26]Table 27Changes in Plasma total protein concentrations (g/L)[a](#tbl27fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 27GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito6873637264727067636263Dahbi7479736773737271717171Chamaa7276717671767673736970Dahman6476657865757266676868Damaa7076747670767073747373Dalilano6676667865747067626463Plasmapheresis GroupBeluc6873697668666667676569Chaddy8080638565896466686965Printanier6167646862717072687074Daoudiya6976747671776870726869Camelia7562766174636473687473Doualiya6576657671746366686868[^27]Table 28Changes in blood aspartate Amino-transferase concentrations (U/L)[a](#tbl28fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 28GroupHorseTimeD-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito242275276285283304302287279275274Dahbi311350293331350359354338336334332Chamaa310365352388365391380378344345348Dahman192251254263255267282256246232226Damaa310365375388345352370369355345334Dalilano192251259263350362378380360346325Plasmapheresis GroupBeluc165348212215219223230219230223240Chaddy231245275289296309221227233236220Printanier300310325349358359295315321305318Daoudiya310365372388376387289299304301302Camelia357319359312345355201221232226210Doualiya335365375388389400230238256306235[^28]Table 29Variations of blood creatine kinase concentrations (U/L)[a](#tbl29fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 29GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito165180172182136135274212182174169Dahbi150160151168152175165166165165153Chamaa149230156268179231133154150136152Dahman112210212250172205189212201196189Damaa149169156162179201200189169156146Dalilano123215212262172250212236226212189Plasmapheresis GroupBeluc120160125189153159105111110110112Chaddy122201191203135183109102112120121Printanier123151128159132149110103114117120Daoudiya123146156156179196123102123120120Camelia306315302332151220132103114116123Doualiya149212146232179202132123112115123[^29]Table 30Changes in blood lactate concentrations (mmol/L)[a](#tbl30fna){ref-type="table-fn"} in jumping horses subsequent to exercise and a plasmapheresis session.Table 30GroupHorseTime (Days/Samples)D-2D-1D0D1D2D3D4S1S2S3S4S5S6S7S8S9S10S11Control GroupAcolito113.71.113.5111.42.41111Dahbi1.215.21.214.21.312.62.21.21.31.21.3Chamaa1.115.4116.9117.83.41.11.111.1Dahman114.8114.6114.73.11.1111.1Damaa1.118.21.119.61.220.94.11.21.11.11.1Dalilano118.61.120.11.119.73.91.11.111.1Plasmapheresis GroupBeluc113.2113.3114.51.110.90.90.9Chaddy1.113.5116114.31.21.11.11.11Printanier123.41.321.91.224.51.31.11.10.90.9Daoudiya114.7114.9115.11.110.80.80.9Camelia1.219.61.120.8121.11.11.1111Doualiya1.217.91.118.11.218.41.110.90.80.9[^30]

[Fig. 1](#fig1){ref-type="fig"} illustrate Lactate concentrations before and following the exercise test standardized by Demonceau and Auvinet \[[@bib2]\], also before and following the modification of the warm-up phase of the same exercise test.Fig. 1**Lactate concentrations in six jumping horses**. **(A)**: Before and following the exercise test standardized by Demonceau and Auvinet. **(B)**: Before and following the modification of the warm-up phase of the same exercise test. The duration of this phase was doubled to 30 min instead of 15 min and steps were substituted by gallop.Fig. 1

1.1. Tables {#sec1.1}
-----------

The following tables containing raw data concerning changes in physiological, heamtological and biochemical parameters of horses subjected to graded physical exercise and plasmapheresis session. Data of each sample are presented individually for animals of the control and plasmapheresis groups. S1, S3, S5: measurements before the exercise; S2, S4, S6: measurements after the exercise; S7: immediate measurement after the plasmapheresis session; S8, S9, S10, S11: post-plasmapheresis measurements at rest. D-2: 48h before plasmapheresis D-1: 24h before plasmapheresis; Day 0: day of plasmapheresis subsequent to the last exercise; D1, D2, D3 and D4 correspond to 24h, 48h, 72h and 96h respectively after plasmapheresis.

2. Experimental design, materials, and methods {#sec2}
==============================================

Investigations were carried out on twelve show jumping horses randomly allocated to two groups: a plasmapheresis group (n = 6) and a control group (n = 6). All horses were healthy and received the same food diet three times a day. First in the morning, they were offered each 1 kg of commercial feed (Destrier, France). Then, in midday, they received each 2.5 kg of barley and its bran (0.5 kg) in addition to 30 g of a vitamin and mineral supplement. Finally, in the evening, horses were fed each 0.5 kg of oats and 2 kg of barley. A supplement of 2.5 kg of alfalfa hay was given for each horse after each food ration distribution. Water was provided ad-libitum.

Horses of both groups underwent each morning an exercise of 30 min/day, during 3 successive days (Day −2, −1 and 0). Blood was sampled before and after exercise. Following the 3rd day exercise (Day 0) and its corresponding subsequent blood sampling, a plasmapheresis session was performed on the horses of the plasmapheresis group while horses of the control group were maintained in the same experimental environment but without being subjected to plasmapheresis. Then blood was sampled from each horse of both groups. Subsequent daily blood samples were taken at the same hour for the following 4 days (Day 1, 2, 3 and 4). All blood samples were obtained using jugular venipuncture. Sampling was realised in the morning between the two first food diets of the day.

In order to verify the effect of plasmapheresis, the physical exercise executed by horses have to comply the condition of inducing a significant raise of several hematobiochemical parameters and specifically providing moderate to high values of lactates. The well-known triangular exercise carried out in the trotter horses by Demonceau and Auvinet \[[@bib2]\] have been first used. This exercise corresponds to succession of warm-up period (15 minutes) and 11 minutes of workloads exercise (steps) and then a recovery period of 10 minutes. Data of lactate concentrations obtained from blood samples taken 5--10 minutes after exercise test finished varied from 2.0 and 3.7 mmol/L ([Fig. 1](#fig1){ref-type="fig"}B). To obtain high values of lactates, the previous exercise test was modified by increasing the duration of the warm-up phase up to 30 min and steps were substituted by gallop. The new warm-up stage consisted on 5 min trot, 3 min of gallop, 5 min of trot, 3 min of gallop, 5 min trot, 3 min of gallop and finally 6 min of trot. The speeds of horses at trot was 240 m/min while it was 350 m/min for gallop. Data of blood lactate concentrations increased by 6 times ([Fig. 1](#fig1){ref-type="fig"}B) varying between 13.2 and 23.4 mmol/L. This new exercise was then used in the following experiment investigating the effect of plasmapheresis.

Plasmapheresis was performed by harvesting of 7L of plasma per horse which are replaced by 7L of NaCl 0.9%. The technique was performed by using a small-sized plasmapheresis machine commercialized by Hemofenix-France utilizing Trackpore technology (Dubna Moscow region-Russian Federation). The machine is equipped with Rosa® type membrane filters with 0.4μm pores. The system is totally automated operating.

Haematological parameters included the number of red blood cells (RBCs), hemoglobin concentration and hematocrit, the mean corpuscular volume (MCV), the mean corpuscular hemoglobin (MCH), the mean corpuscular hemoglobin concentration (MCHC), the number of platelets and also the number of white blood cells (WBCs) and the count of lymphocytes, monocytes, eosinophils and granulocytes. All these parameters were determined using a veterinary cell-counter automate, the Celltac VET MEK-6550 haematology (Nihon Kohden, Tomioka-Japan) and its reagents, Hemolynac·3 MEK-660I, Isotonac·4 MEK-641I, Cleanac MEK-520I (Celltac VET MEK-6550 J/K haematology, Nihon Kohden, Tomioka-Japan). Concerning the biochemical parameters, the concentrations of albumin, globulin, total protein, glucose, alkaline phosphatase (ALP), aspartate aminotransferase (AST), gamma glutamyl transferase (GGT), total bilirubin, lactate, creatinine kinase (CK), urea, creatinine, calcium, sodium and potassium were determined using the veterinary Skyla-VB1 automate analyzer (Lite-On Technology Corporation, Hsinchu-Taiwan). All the chemical reactions completed inside a circular and transparent plastic reagent disc (Equine Panel- Product code 900-150, skyla™ VB1 reagent disc, Hsinchu-Taiwan), containing different reaction cuvettes with specific assay reagent for each measured parameter. Concentrations quantified by photometric measurement of the absorbance changes arising from the chemical reactions in cuvettes' disc are automatically given by the analyzer.

Lactate concentration was assayed using the portable analyzer Lactate-Pro™ 2. This test meter is based on a reaction of the blood lactate with a reagent in the Lactate-Pro™ 2 Test Strip (Busimedic®, S.L, San Sebastián-Spain). To validate and to ensure the accuracy of this technique, blood lactate concentrations measured using the Lactate-Pro™2 were compared to those measured by a reference analyzer, COBAS™ Gen.2 using the reagent COBAS INTEGRA Lactate Gen.2 (Roche®, Maylan-France). These analyses were conducted on specimens of six Athlete show jumping horses having performed the developed exercise, as previously described. Blood was sampled before and after the exercise and lactate concentration was immediately assayed by Lactate-Pro™2 and COBAS™ Gen.2 analyzers. Measurements from both instruments were tested for correlation.

**For further information concerning the experimental procedures** please see the research article \[[@bib1]\] accompanying this data paper.
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[^1]: Normal rectal temperature of adult horse: 37.0--38.0 °C \[[@bib3]\].

[^2]: Normal heart rate of adult horse: 30--40 beats per minute \[[@bib3]\].

[^3]: Normal respiratory rate of adult horse: 8--20 breaths per minute \[[@bib4]\].

[^4]: Reference range: 6.70--12.90.10^6^/μL \[[@bib5]\].

[^5]: Reference range: 11.0--19.0 g/dl \[[@bib6]\].

[^6]: Reference range: 32.0--53.0 g/dl \[[@bib6]\].

[^7]: Reference range: 37.0--59.0 fL \[[@bib6]\].

[^8]: Reference range: 12.3--19.9 pg \[[@bib7]\].

[^9]: Reference range: 31--38.6 g/dl \[[@bib7]\].

[^10]: Reference range: 100--270 10^3^/μL \[[@bib5]\].

[^11]: Reference range: 5.4--14.3 10^3^/μL \[[@bib5]\].

[^12]: Reference range: 1.5--7.7 10^3^/μl \[[@bib6]\].

[^13]: Reference range: 0--0.8 10^3^/μl \[[@bib8]\].

[^14]: Reference range: 0--1.0 10^3^/μl \[[@bib6]\].

[^15]: Reference range: 2.3--8.6 10^3^/μl \[[@bib7]\].

[^16]: Reference range: 3.5--6.0 mmol/L \[[@bib9]\].

[^17]: Reference range: 1.2 à 3.6 mmol/L \[[@bib9]\].

[^18]: Reference range: 0.8--1.5 mg/dl \[[@bib10]\].

[^19]: Reference value: \< 250U/L \[[@bib5]\].

[^20]: Reference value: \<30 U/l \[[@bib5]\].

[^21]: Reference value: 0.5--2.1 mg/dl \[[@bib10]\].

[^22]: Reference range: 132--142 mmol/L \[[@bib11],[@bib12]\].

[^23]: Reference range: 3.8--5.2 mmol/L \[[@bib9]\].

[^24]: Reference range: 10.8--12.9 mg/dL \[[@bib10]\].

[^25]: Reference range: 26--37g/L \[[@bib5]\].

[^26]: Reference range: 25--45 g/L \[[@bib5]\].

[^27]: Reference range: 62.5--75.0 g/L \[[@bib13]\].

[^28]: Reference range: 160--412 U/L \[[@bib11],[@bib12]\].

[^29]: Reference range: 60--330 U/L \[[@bib11],[@bib12]\].

[^30]: Reference value: \< 2.5 mmol/L \[[@bib9]\].
